POS0939 BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY.

A. Deodhar, D. Van der Heijde, L. S. Gensler, H. Xu, K. Gaffney, H. Dobashi, W. P. Maksymowych, M. Rudwaleit, M. Magrey, D. Elewaut, M. Oortgiesen, C. Fleurinck, A. Ellis, T. Vaux, J. Smith, X. Baraliakos. POS0939 BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. Annals of the Rheumatic Diseases. 2022 May 23; 81(Suppl 1):772-773.

2022
https://researcherprofiles.org/profile/344527243

A. Deodhar, D. Van der Heijde, L. S. Gensler, H. Xu, K. Gaffney, H. Dobashi, W. P. Maksymowych, M. Rudwaleit, M. Magrey, D. Elewaut, M. Oortgiesen, C. Fleurinck, A. Ellis, T. Vaux, J. Smith, X. Baraliakos